C-reactive protein activates complement in infarcted human myocardium. 2003

Remco Nijmeijer, and Wim K Lagrand, and Yvonne T P Lubbers, and Cees A Visser, and Chris J L M Meijer, and Hans W M Niessen, and C Erik Hack
Institute for Cardiovascular Research, Vrije Universiteit Medical Center, Amsterdam, The Netherlands.

Circulating levels of C-reactive protein (CRP) constitute a cardiovascular risk marker. Immunohistochemical studies have revealed co-localization of CRP and activated complement in human infarcted myocardium suggesting CRP to enhance inflammation in ischemic myocardium by inducing local complement activation. The aim was to establish whether CRP activates complement in infarcted human myocardium and to assess the relationship between this activation and the duration of infarction. Myocardial tissue samples from 56 patients that had died from acute myocardial infarction were evaluated. Specimens were taken from infarcted as well as noninfarcted sites of the heart. CRP-mediated complement activation was assessed by immunohistochemistry and by measuring levels of complement, CRP, and CRP-complement complexes, specific markers for CRP-mediated activation, in homogenates of the heart. Infarctions of 12 hours to 5 days had significantly more extensive depositions of complement and CRP and contained significantly more CRP, activated complement, and CRP-complement complexes than infarctions that were less than 12 hours old. Levels of CRP complexes correlated significantly with CRP and complement concentrations in the infarctions, as well as with the extent of complement and CRP depositions as measured via immunohistochemistry. Specific activation products of CRP-mediated activation of complement are increased in infarcts of more than 12 hours in duration and correlate with the extent of complement depositions. Hence, CRP seems to enhance local inflammatory reactions ensuing in human myocardial infarcts of more than 12 hours duration.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003181 Complement C4 A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B. C4 Complement,C4 Complement Component,Complement 4,Complement C4, Precursor,Complement Component 4,Pro-C4,Pro-complement 4,C4, Complement,Complement Component, C4,Complement, C4,Component 4, Complement,Component, C4 Complement,Pro C4,Pro complement 4
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013223 Statistics as Topic Works about the science and art of collecting, summarizing, and analyzing data that are subject to random variation. Area Analysis,Estimation Technics,Estimation Techniques,Indirect Estimation Technics,Indirect Estimation Techniques,Multiple Classification Analysis,Service Statistics,Statistical Study,Statistics, Service,Tables and Charts as Topic,Analyses, Area,Analyses, Multiple Classification,Area Analyses,Classification Analyses, Multiple,Classification Analysis, Multiple,Estimation Technic, Indirect,Estimation Technics, Indirect,Estimation Technique,Estimation Technique, Indirect,Estimation Techniques, Indirect,Indirect Estimation Technic,Indirect Estimation Technique,Multiple Classification Analyses,Statistical Studies,Studies, Statistical,Study, Statistical,Technic, Indirect Estimation,Technics, Estimation,Technics, Indirect Estimation,Technique, Estimation,Technique, Indirect Estimation,Techniques, Estimation,Techniques, Indirect Estimation
D014020 Tissue Extracts Preparations made from animal tissues or organs (ANIMAL STRUCTURES). They usually contain many components, any one of which may be pharmacologically or physiologically active. Tissue extracts may contain specific, but uncharacterized factors or proteins with specific actions. Extracts, Tissue

Related Publications

Remco Nijmeijer, and Wim K Lagrand, and Yvonne T P Lubbers, and Cees A Visser, and Chris J L M Meijer, and Hans W M Niessen, and C Erik Hack
April 2005, Journal of clinical pathology,
Remco Nijmeijer, and Wim K Lagrand, and Yvonne T P Lubbers, and Cees A Visser, and Chris J L M Meijer, and Hans W M Niessen, and C Erik Hack
August 2003, Immunology,
Remco Nijmeijer, and Wim K Lagrand, and Yvonne T P Lubbers, and Cees A Visser, and Chris J L M Meijer, and Hans W M Niessen, and C Erik Hack
January 2008, Journal of the American College of Surgeons,
Remco Nijmeijer, and Wim K Lagrand, and Yvonne T P Lubbers, and Cees A Visser, and Chris J L M Meijer, and Hans W M Niessen, and C Erik Hack
September 1986, Journal of immunology (Baltimore, Md. : 1950),
Remco Nijmeijer, and Wim K Lagrand, and Yvonne T P Lubbers, and Cees A Visser, and Chris J L M Meijer, and Hans W M Niessen, and C Erik Hack
January 2023, Frontiers in immunology,
Remco Nijmeijer, and Wim K Lagrand, and Yvonne T P Lubbers, and Cees A Visser, and Chris J L M Meijer, and Hans W M Niessen, and C Erik Hack
July 1990, Journal of immunology (Baltimore, Md. : 1950),
Remco Nijmeijer, and Wim K Lagrand, and Yvonne T P Lubbers, and Cees A Visser, and Chris J L M Meijer, and Hans W M Niessen, and C Erik Hack
January 1982, Annals of the New York Academy of Sciences,
Remco Nijmeijer, and Wim K Lagrand, and Yvonne T P Lubbers, and Cees A Visser, and Chris J L M Meijer, and Hans W M Niessen, and C Erik Hack
June 1973, Die Medizinische Welt,
Remco Nijmeijer, and Wim K Lagrand, and Yvonne T P Lubbers, and Cees A Visser, and Chris J L M Meijer, and Hans W M Niessen, and C Erik Hack
October 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Remco Nijmeijer, and Wim K Lagrand, and Yvonne T P Lubbers, and Cees A Visser, and Chris J L M Meijer, and Hans W M Niessen, and C Erik Hack
January 1986, International archives of allergy and applied immunology,
Copied contents to your clipboard!